Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.335
-0.095 (-2.77%)
At close: Apr 28, 2026, 4:00 PM EDT
3.260
-0.075 (-2.25%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Indaptus Therapeutics Employees
Indaptus Therapeutics had 5 employees as of December 31, 2025. The number of employees decreased by 2 or -28.57% compared to the previous year.
Employees
5
Change (1Y)
-2
Growth (1Y)
-28.57%
Revenue / Employee
n/a
Profits / Employee
-$4,169,783
Market Cap
7.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 41 |
| TransCode Therapeutics | 12 |
| Processa Pharmaceuticals | 12 |
| MetaVia | 8 |
| Immuron | 7 |
| Acurx Pharmaceuticals | 4 |
| Creative Medical Technology Holdings | 4 |
| PharmaCyte Biotech | 2 |
INDP News
- 4 months ago - Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit - GlobeNewsWire
- 5 months ago - Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics Provides Clinical Update - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference - GlobeNewsWire
- 9 months ago - Indaptus Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 months ago - Indaptus Therapeutics, Inc. Announces Additional Sale of $3.4 Million in Private Placement of Convertible Notes and Warrants - GlobeNewsWire
- 10 months ago - Indaptus Therapeutics Announces Reverse Stock Split - GlobeNewsWire